آخر تحديث :
08/05/2024
InfoStab
Infostab
قائمة المركبات
قائمة المركبات
ملخص القوائم
ملخص القوائم
ابحث عن التوافق
ابحث عن التوافق
جدول توافق موقع ص
جدول توافق موقع ص
مراجع
مراجع
فرق البحث
فرق البحث
Valistab
Valistab
الملصق
الملصق
الروابط
الروابط
الرعاة
الرعاة
الكتاب
الكتاب
دليل المستخدم
دليل المستخدم
النشرة الإخبارية
النشرة الإخبارية
المضادة للفيروسات   Ganciclovir sodium  
حقن
الاستقرار في حلول استقرار مخاليط العوامل التي تؤثر على الاستقرار التوافق طريقة التعاطي مراجع Pdf
   التركيب الكيميائي  

حجز الاسم التجاري   حجز الاسم التجاري     

تحذير الأسماء التجاريه المختلفه قد تحتوي علي محتوي إضافات مختلفة حسب الدوله و المعمل
Ceptyl المكسيك
Ciganclor الأرجنتين
Citovirax إيطاليا
Cymevan فرنسا
Cymeven ألمانيا
Cymevene أستراليا, أيسلندا, إسبانيا, إيران, إيطاليا, الإكوادور, الإمارات العربية المتحدة, البرازيل, البرتغال, الدنمارك, الروسية, السويد, المكسيك, النرويج, النمسا, ايرلندا, بريطانيا العظمي, بلجيكا, بولندا, بيرو, تركيا, تشيلي, زيلاندا الجديدة, سويسرا, فنزويلا, فنلندا, كرواتيا, كولومبيا, لوكسمبورغ, ماليزيا, مصر, هنغاريا, هولندا, يونان
Cymevir البرازيل
Cytovene الولايات المتحدة, كندا
Ganciclovir ألمانيا, الأرجنتين, الإكوادور, المكسيك, الولايات المتحدة, تشيلي, فرنسا, كندا
Gavir الهند
Inglav المكسيك
Natclovir الهند
Pharcigave المكسيك
Umecortil المكسيك, كولومبيا
Viraprex المكسيك
مراجع   حقن   مراجع : Ganciclovir sodium  
نوع منشور
3 مجلة Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
4 مجلة Zazempa V, Morgenszejn J, Paul M, Astier A.
Reconstitution centralisée du ganciclovir : méthode de contrôle et étude de stabilité.
Act Pharm Biol Clin 1995 ; 8: 525-528.
36 مجلة Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC.
Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods.
Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
59 مجلة Trissel LA, Gilbert DL, Martinez JF, Kim MC.
Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
67 مجلة Outman WR, Mitrano FP, Baptista RJ.
Visual compatibility of ganciclovir sodium and parenteral nutrient solution during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 1538-1539.
69 مجلة Visor GC, Lin LH, Jackson SE, Winterle JS, Lee G, Kenley RA.
Stability of ganciclovir sodium (DHPG sodium) in 5% dextrose or 0.9% sodium chloride injections.
Am J Hosp Pharm 1986 ; 43: 2810-2812.
70 مجلة Silvestri AP, Mitrano FP, Baptista RJ, Williams DA.
Stability and compatibility of ganciclovir sodium in 5% dextrose injection over 35 days.
Am J Hosp Pharm 1991 ; 48: 2641-2643.
72 مجلة Johnson CE, Jacobson PA, Chan E.
Stability of ganciclovir sodium and amino acids in parenteral nutrient solutions.
Am J Hosp Pharm 1994 ; 51: 503-508.
73 مجلة Lor E, Takagi J.
Visual compatibility of foscarnet with other injectable drugs.
Am J Hosp Pharm 1990 ; 47: 157-159.
74 مجلة Mulye NV, Turco SJ, Speaker TJ.
Stability of ganciclovir sodium in an infusion-pump syringe.
Am J Hosp Pharm 1994 ; 51: 1348-1349.
76 مجلة Parasrampuria J, Li LC, Stelmach AH, Sykes TR, Gordon GA.
Stability of ganciclovir sodium in 5% dextrose injection and in 0.9% sodium chloride injection over 35 days.
Am J Hosp Pharm 1992 ; 49: 116-118.
81 مجلة Trissel LA, Martinez JF.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 672-678.
84 مجلة Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499.
88 مجلة Mole L, Oliva C, O?Hanley P.
Extended stability of ganciclovir for outpatient parenteral therapy for cytomegalovirus retinitis.
J Acquired Immune Defic Syndr 1992 ; 5: 354-358.
99 مجلة Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
169 مجلة Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363.
182 مجلة Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
201 مجلة Thompson DF, Allen LV, Stiles ML.
Visual compatibility of enalaprilate with selected intravenous medications during simulated Y-site injection.
Am J Hosp Pharm 1990 ; 47: 2530-2531.
244 مجلة Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
245 مجلة Phaypradith S, Vigneron J, Perrin A, Durney-Archeray MJ, Hoffman MA, Hoffman M.
Stability of ganciclovir sodium (Cymevan*) after dilution in PVC infusions and polypropylene syringes.
J Pharm Belg 1992 ; 47: 494-498.
248 مجلة Trissel LA, Martinez JF.
Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection.
Am J Hosp Pharm 1993 ; 50: 300-304.
249 مجلة Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
251 مجلة Trissel LA, Gilbert DL, Martinez JF.
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
253 مجلة Trissel LA, Chandler SW, Folstad JT.
Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1990 ; 47: 2525-2528.
299 مجلة Trissel LA, Martinez JF, Gilbert DL.
Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
300 مجلة Trissel LA, Gilbert DL, Martinez JF.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
301 مجلة Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM.
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
307 مجلة Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799.
334 مجلة Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992.
335 مجلة Trissel LA, Bready BB, Kwan JW, Santiago NM.
Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 402-406.
479 مجلة Min DI, Brown T, HWang GC.
Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 2964-2966.
492 مجلة Trissel LA, Parks NPT, Santiago NM.
Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2186-2189.
496 مجلة Lor E, Sheybani T, Takagi J.
Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
Am J Hosp Pharm 1991 ; 48: 744-746.
604 مختبر Stabilité des médicaments dans l'Intermate® SV50, 100, 200
Baxter 1998
905 مجلة Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017.
921 مجلة Trissel LA, Gilbert DL, Martinez JF.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 284-292.
1410 مجلة Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1415 مجلة Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M.
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
JPEN 1999 ; 23: 67-74.
1423 مجلة Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1625 مجلة Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1754 مجلة Trissel LA, Gilbert DL, Wolkin AC.
Compatibility of docetaxel with selected drugs during simulated Y-site administration.
Int J Pharm Compound 1999 ; 3: 241-244.
1925 مجلة Trissel LA , Williams KY, Gilbert DL.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
J Am Pharm Assoc 2000 ; 40: 515-519.
1953 مجلة Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982 مجلة Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2247 مجلة Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
3626 مختبر Tacrolimus (Prograf®) - Résumé des Caractéristiques du Produit
Astellas Pharma 2014
3662 مختبر Foscavir (Foscarnet®) - Summary of Product Characteristics
Clinigen 2014
3728 مجلة Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B.
Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3791 الملصق Sadou Yaye H, Burtet E, Hamel C, Aljhni R, Gard C, Tilleul P.
Étude de la compatibilité physico-chimique du phloroglucinol injectable durant les mélanges au sein des tubulures en Y.
Apifh Congress, Paris November 2014 2014
3796 مجلة Morlet N, Young S, Naidoo D et al.
High dose intravitreal ganciclovir for CMV retinitis: a shelf life and cost comparison study.
Br Ophtalmol 1995 ; 79: 753-755.
3883 مختبر Ceftazidime - Résumé des caractéristiques du produit
Arrow 2016
4021 مجلة Guichard N, Bonnabry P, Rudaz S, Fleury S.
Long-term stability of ganciclovir in polypropylene containers at room temperature.
J Oncol Pharm Practice 2017 ;25,2: 303-308
4521 مجلة Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B.
Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit.
Pharmaceutical Technology in Hospital Pharmacy 2020
  Mentions Légales